Genpact Ltd (G) concluded trading on Thursday at a closing price of $42.04, with 8.15 million shares of worth about $342.75 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 8.41% during that period and on May 08, 2025 the price saw a loss of about -15.16%. Currently the company’s common shares owned by public are about 174.87M shares, out of which, 160.21M shares are available for trading.
Stock saw a price change of -14.62% in past 5 days and over the past one month there was a price change of -6.74%. Year-to-date (YTD), G shares are showing a performance of -2.12% which increased to 30.20% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $30.38 but also hit the highest price of $56.76 during that period. The average intraday trading volume for Genpact Ltd shares is 1.48 million. The stock is currently trading -12.41% below its 20-day simple moving average (SMA20), while that difference is down -14.70% for SMA50 and it goes to -4.47% lower than SMA200.
Genpact Ltd (NYSE: G) currently have 174.87M outstanding shares and institutions hold larger chunk of about 92.53% of that.
The stock has a current market capitalization of $7.35B and its 3Y-monthly beta is at 1.03. PE ratio of stock for trailing 12 months is 14.32, while it has posted earnings per share of $2.94 in the same period. Its PEG reads 1.65 and has Quick Ratio of 2.16 while making debt-to-equity ratio of 0.58. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for G, volatility over the week remained 3.16% while standing at 2.96% over the month.
Stock’s fiscal year EPS is expected to rise by 5.99% while it is estimated to increase by 8.40% in next year. EPS is likely to shrink at an annualized rate of 8.66% for next 5-years, compared to annual growth of 12.75% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by TD Cowen on February 07, 2025 offering a Buy rating for the stock and assigned a target price range of between $45 and $60 to it. Coverage by Jefferies stated Genpact Ltd (G) stock as a Buy in their note to investors on January 21, 2025, suggesting a price target of $55 for the stock. On July 17, 2024, JP Morgan Upgrade their recommendations, while on January 30, 2024, Mizuho Initiated their ratings for the stock with a price target of $40. Stock get a Neutral rating from Robert W. Baird on December 15, 2023.
